The peripheral production of leptin by adipose tissue and its putative effect as a signal of satiety in the central nervous system suggest that leptin gains access to the regions of the 
Introduction
Leptin, the product of the ob gene (1) , is a 16-kD protein monomer that has been identified as a blood-borne factor that regulates appetite (2) (3) (4) . Leptin is secreted by peripheral adipocytes in vivo in response to stimuli that include food intake (5) and insulin administration (6) , and appears to serve as a signal of satiety. Increases in ob gene mRNA expression have been observed in mice and rats after insulin administration (7), food intake (7), increased glucocorticoid levels, and decreased sympathetic neural activity (8) ; ob mRNA was decreased by fasting, but restored to normal levels upon refeeding (7, 9) or insulin administration (7) . When genetically obese, leptin-deficient ob/ob mice received leptin either intraperitoneally or intracerebroventricularly, the mice demonstrated dose-dependent weight loss and reduction in food intake compared with control animals (2-4, 10, 11) . Decreased serum glucose and insulin concentrations (10, 11) and increased metabolic rates (2) also have been observed in response to exogenous leptin administration in ob/ob mice. Unlike ob/ob mice, however, obese humans are not deficient in leptin. In fact, like db/db mice (5), they show increased ob gene expression and, consequently, elevated leptin concentrations in the blood as compared with normal-weight subjects. Evidence to date indicates that, in the absence of leptin deficiency, decreased access of leptin to its receptor site or decreased sensitivity at the receptor site may mediate obesity in humans (12) (13) (14) .
Leptin mRNA has not been identified in brain tissue (15) . This observation, combined with the peripheral production of leptin in adipose tissue and its likely target in the brain (1), points to the presence of a transport system that mediates delivery of circulating leptin to brain cells. To date, leptin binding sites have been identified in the mouse choroid plexus and leptomeninges (16) (17) (18) (19) . While these leptin receptors will allow the distribution of circulating leptin into cerebrospinal fluid (CSF) 1 within the ventricles and subarachnoid space, they allow minimal distribution of circulating leptin into brain interstitial fluid that bathes brain receptors. Direct transport of leptin from blood to brain interstitium is possible via receptormediated transcytosis through the brain capillary endothelium (20) , which makes up the blood-brain barrier (BBB) in vivo. For example, the BBB insulin, insulin-like growth factor (IGF), and transferrin receptors mediate the BBB transport of insulin, IGFs, and transferrin (21) (22) (23) (24) (25) . If a leptin receptor did exist at the brain capillary endothelium, this receptor would not have been detectable in previous studies, which used film autoradiography (16) (17) (18) (19) , a technique that lacks the resolution for detection of peptide binding to parenchymal capillaries.
Therefore, the present studies assess the saturable binding and endocytosis of 125 I-leptin by isolated human brain capillaries, an in vitro model of the human BBB.
Methods
Chemicals. Mouse recombinant leptin was expressed in insect High Five cells using a baculovirus expression system. Leptin secreted into the growth medium was purified by ammonium sulfate precipitation, DEAE Sephacel anion exchange, and Sephacryl S100HR gel filtration chromatography. The isolated leptin decreased overnight food consumption when injected intraperitoneally into ob/ob mice at doses Ͻ 10 g/mouse. Leptin (125 g/ml; 7.8 M) was radiolabeled with iodine-125 according to the method of Bolton and Hunter (26) . Briefly, Isolated human brain capillaries and capillary membranes. Human brains were obtained from one male and one female (male: 65 yr, weight 44.3 kg, height 135 cm; female: 64 yr, weight 52.8 kg, height 169 cm) at 20-24 h postmortem from the UCLA Division of Neuropathology (Dr. Harry V. Vinters). Capillaries were isolated by mechanical homogenization as described previously (27) . The final capillary pellet was suspended in a cryopreservation buffer (0.02 M Tris, 0.25 M sucrose, and 2 mM dithiothreitol) and stored at Ϫ 70 Њ C under liquid nitrogen. Human brain capillary membranes were isolated from the capillaries of the female donor on the same day as the capillary isolation according to the method of Lidinsky and Drewes (29) . Both capillaries and plasma membranes isolated by these techniques maintain biochemical characteristics of the intact BBB, as characterized previously in this laboratory for the human BBB insulin receptor (21) .
Uptake of 125 I-leptin into isolated human brain capillaries. Isolated human brain microvessels from the male donor were thawed at room temperature and resuspended in Ringer-Hepes buffer (RHB; 141 mM NaCl, 4 mM KCl, 2.8 mM CaCl 2 , 10 mM Hepes, pH 7.4) with 0.1% HSA. The microvessels were incubated with 125 I-leptin at a final concentration of 2.2 Ci/ml (13.7 nM) for up to 120 min. Incubations were performed in triplicate in 0.45 ml of RHB with 0.1% HSA in plastic 12 ϫ 75 mm test tubes. At the end of the incubation, 400 l was transferred to small Beckman microfuge tubes and centrifuged at 10,000 g for 45 s. The supernatant was removed and reserved for TCA precipitation analysis. The microvessel pellet was placed in 0.5 ml 1 N NaOH for measurement of iodine-125 by gamma counting (Gamma 5500 gamma counter; Beckman Instruments, Inc., Fullerton, CA), then heated at 60 Њ C for 30 min to solubilize the capillary protein. Protein concentration was determined using the bicinchoninic acid protein assay (Pierce Chemical Co.).
The internalization of 125 I-leptin was determined with an acid wash technique as described previously (30) . This technique, as used with [ 125 I]insulin, removed completely the cell surface-bound radioactivity without damaging cell integrity.
125
I-Leptin was incubated with isolated microvessels as described above. At the end of the incubation, the microvessels were centrifuged and incubated in 450 l icecold acid wash solution (0.12 M NaCl, 0.02 M sodium barbital, 0.028 M sodium acetate, pH 3) over ice for 6 min to remove 125 I-leptin bound to the outer capillary wall. 400 l was pipetted to a small Beckman microfuge tube and centrifuged at 10,000 g for 45 s. The capillary pellet was analyzed for iodine-125 and protein content as described above.
Leptin binding to plasma membranes. Because of the rapid internalization of leptin into intact human brain microvessels, brain capillary endothelial plasma membranes were used to determine the affinity of leptin binding at the human BBB. Human plasma membranes (115 g of membrane protein per tube) were incubated with 0.02 Ci (0.625 nM) I-leptin and porcine insulin or IGF-1 (final concentration 100 nM). All incubations were performed in triplicate. The next morning, the contents of each incubation tube were combined with 4 ml ice-cold PBS (0.01 M, pH 7.4) and filtered immediately by rapid vacuum filtration through preconditioned Whatman GF-D borosilicate glass microfiber filters (0.68 mm thickness, particle retention up to 2.7 m; Whatman LabSales, Hillsboro, OR). Filters were preconditioned by soaking for 1 h in ice-cold PBS with 5% HSA to minimize nonspecific binding to the filter. After the initial filtration, the incubation tube was washed once with 4 ml icecold PBS, and this solution was used to wash the filter. Radioactivity remaining on filters was determined by gamma counting.
Data analysis. All measurements were performed in triplicate. Parameters governing the binding of 125 I-leptin to human capillary plasma membranes were estimated by nonlinear least-squares regression using the software program BMDP (BMDP Statistical Software, Los Angeles, CA), with initial parameter estimates determined by graphical analysis according to the Scatchard method (31).
Results
After cryopreservation, human brain microvessels were intact (Fig. 1, top ) . At 37 Њ C (Fig. 1, bottom left ) , leptin binding to isolated capillaries increased over the course of the 120-min incubation, with maximum binding at 120 min of 68.6 Ϯ 4.3% (mean Ϯ SE, n ϭ 3) binding of 125 I-leptin per milligram of capillary protein (mg p ). The majority of 125 I-leptin binding was resistant to removal by acid wash, indicating incorporation into the capillary membrane or endocytosis at physiologic temperature. As with total binding, acid-resistant binding increased over the incubation time, with 44.3 Ϯ 3.6% bound per mg p at 120 min. The temperature dependence of leptin binding and internalization was evident (Fig. 1, bottom right ) . Over the same incubation period at 4 Њ C, binding of leptin increased only marginally between 30 and 120 min. At 120 min, total binding was 24.5 Ϯ 3.3% per mg p . This binding was almost entirely acid wash resistant, with 20.4 Ϯ 1.5% bound per mg p at 120 min.
A small degree of metabolism or degradation of 125 I-leptin to non-acid-precipitable products by the isolated capillaries was noted. The TCA-soluble medium radioactivity increased 6 and 0%, respectively, at 37 and 4 Њ C after a 120-min incubation.
Binding of 125 I-leptin to isolated plasma membranes from the human BBB was saturable in the presence of increasing concentrations of nonradiolabeled leptin (Fig. 2, inset ) . Scatchard analysis of the binding data (Fig. 2, main graph ) 
Discussion
The results of the present experiments demonstrated that leptin was bound and internalized by isolated human brain capillaries. Both binding and endocytosis were temperature dependent (Fig. 1) . Endocytosis was monitored in these experiments with isolated microvessels with the acid wash technique (30) . The movement of peptide into a postmembrane space that is resistant to acid wash is not abolished by cold temperature (32) and is independent of ATP (33) . Since incubation at 4 Њ C suppressed receptor binding to a greater extent than peptide movement into the acid wash-resistant compartment (Fig. 1), we measured the saturation of receptor binding in isolated plasma membranes (Fig. 2) , where endocytosis is absent. Binding to human brain microvessel membranes was specific and was inhibited competitively by increasing concentrations of leptin, but was not altered by the presence of insulin or IGF-1 (Fig. 2) . The behavior of leptin in this in vitro model system was similar to that previously documented for insulin, IGFs, and transferrin in the same human BBB model (Table I) .
These studies indicate that a leptin receptor functions at the brain capillary endothelium, which comprises the BBB in vivo and which segregates blood from brain interstitial fluid. Therefore, the BBB leptin receptor functions in parallel with the previously reported leptin receptor at the choroid plexus epithelium (16) (17) (18) (19) , which comprises the blood-CSF barrier in vivo and segregates blood from CSF. The choroid plexus leptin receptor may mediate the uptake of circulating leptin into CSF. Leptin is present in the CSF of humans and the CSF/ plasma ratio for leptin is inversely related to the plasma leptin concentration, suggesting the presence of a saturable transport system for leptin at the choroid plexus (14) . Similarly, recent studies provide evidence for saturable transport of nous injection in mice: 20 min after administration, ‫ف‬ 72% of radioactivity in serum and 60% of radioactivity in the brain represented intact peptide. Similar results were observed in this laboratory after intravenous administration to rats, with 70% (serum) and 50% (brain) intact radiolabeled leptin present 30 min after administration (Golden, P.L., and W.M. Pardridge, unpublished observations). The interpretation of data pertaining to the transport of metabolically labile peptide into brain after intravenous injection of the peptide is problematical owing to the rapid conversion of radiolabeled peptide into low molecular weight radioactive metabolites, which also may be transported into brain. To demonstrate saturable transport of [ 125 I]insulin into brain in vivo, it was necessary to perform transport studies after intraarterial infusion in suckling animals, in which peripheral insulinases are downregulated (22) .
The presence of specific receptors for leptin at the brain capillary endothelium, at the choroid plexus endothelium, and on brain cells (16, 37, 38) is consistent with recent studies showing that multiple mRNA splice variants exist for the leptin receptor in the brain (38, 39) . These receptors may be differentially regulated. For example, leptin does not inhibit food intake in the db/db mouse, yet there is no apparent functional impairment in the choroid plexus leptin receptor in this species (19) . Therefore, it is important in future studies to determine the activity of the BBB leptin receptor in obesity models, since the leptin receptor at the BBB may play a principal role in regulating the distribution of circulating leptin to brain cells. 
